SC
GILD icon

Sierra Capital’s Gilead Sciences GILD Stock Holding History

Sierra Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-921
Closed -$57K – 687
2022
Q2 		$57K Sell
921
-72
-7% -$4.46K 0.01% 318
2022
Q1 		$59K Sell
993
-6
-0.6% -$384 0.01% 329
2021
Q4 		$73K Buy
999
+78
+8% +$5.37K 0.01% 319
2021
Q3 		$64K Hold
921
– – 0.01% 295
2021
Q2 		$63K Hold
921
– – 0.01% 276
2021
Q1 		$60K Buy
+921
New +$59.4K 0.01% 267

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sierra Capital's GILD Position: Q3 2022 in Review

Sierra Capital sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 921 shares — an estimated $57K sold.

Sierra Capital first reported a position in GILD in Q1 2021 and held it in 6 quarters. The position peaked at $73K in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Sierra Capital reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Sierra Capital sold 921 Gilead Sciences shares in Q3 2022, an estimated $57K.
  • Sierra Capital first reported a position in Gilead Sciences in Q1 2021 and held it in 6 quarters.
  • Sierra Capital's Gilead Sciences position peaked at $73K in Q4 2021.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Sierra Capital's 13F filing for Q3 2022, filed 4 Nov 2022.